Last reviewed · How we verify
NCT07080957: PectoMesh
Comparison of Mesh-Based and Mesh-Free Laparoscopic Pectopexy in Uterus-Preserving Surgery for Apical Prolapse
NA trial testing Mesh-free laparoscopic uterus-preserving pectopexy in Pelvic Organ Prolapse in 81 participants. Completed in 14 July 2025.
14 July 2025
Quick facts
| Lead sponsor | Havva Betül Bacak |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 81 |
| Start date | 16 April 2025 |
| Primary completion | 14 July 2025 |
| Estimated completion | 14 July 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Mesh-free laparoscopic uterus-preserving pectopexy
- Mesh-based laparoscopic uterus-preserving pectopexy
Conditions studied
- Pelvic Organ Prolapse — all drugs for Pelvic Organ Prolapse →
Sponsor
Havva Betül Bacak — full company profile →
Who can join
Adults 18 to 70, female only, with Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This retrospective cohort study compares anatomical and functional outcomes of mesh-based and mesh-free laparoscopic uterus-preserving pectopexy in women with apical pelvic organ prolapse. A total of 81 patients were included between 2021 and 2024 (mesh-based: 41, mesh-free: 40). Key outcomes assessed included operative time, blood loss, hospital stay, anatomical correction (POP-Q), sexual function (PISQ-12), and complications. Both techniques significantly improved prolapse and sexual function. Mesh-based pectopexy offered superior apical and posterior support, while mesh-free pectopexy was associated with longer vaginal length and longer operative time. Complication and recurrence rates were low and similar across groups. The findings suggest that both techniques are effective, and surgical approach should be tailored to patient preference and clinical context.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07080957
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pelvic Organ Prolapse
Currently open trials in the same condition.
- NCT07471464 — Centered Surgery - Preoperative Counseling and Patient Satisfaction · recruiting
- NCT07104292 — Pelvic Floor Muscle Training During Pregnancy · NA · recruiting
- NCT07218016 — The AccelERate Trial · NA · recruiting
- NCT07114029 — VNOTES Approach in Mesh Free Sacrocolpopexy: A Functional and Anatomic Evaluation · NA · recruiting
- NCT07082023 — Comparison of V-NOTES and Laparoscopic Mesh-Free Sacrocolpopexy Techniques · NA · recruiting
Other Havva Betül Bacak trials
Trials by the same sponsor.
- NCT07248579 — Turkish Validation of the Pregnancy-Specific Anxiety Tool (PSAT) · completed
- NCT07426666 — Vaginal Cuff Bupivacaine Injection for Postoperative Pain · NA · completed
- NCT07082023 — Comparison of V-NOTES and Laparoscopic Mesh-Free Sacrocolpopexy Techniques · NA · recruiting
- NCT07248540 — IV Magnesium in the Treatment of Acute Dysmenorrhea · NA · recruiting
- NCT07094776 — Evaluation of MG53 (TRIM72) Levels in Women With Polycystic Ovary Syndrome: An Observational Study · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07080957 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Havva Betül Bacak
- Last refreshed: 5 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07080957.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing